NCT03626636 - A Clinical Trial Designed To Evaluate The Safety And Exploratory Efficacy Of 1.0 Mg Luminate® (Alg-1001) As A Treatment For Non-Exudative Macular Degeneration | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

August 1, 2017

Primary Completion Date

April 4, 2019

Study Completion Date

April 4, 2019

Conditions

Dry Age-related Macular Degeneration

Interventions

DRUG

Risuteganib

Subjects injected intravitreally with 1.0mg of Luminate®

OTHER

Sham

Sham injection

Trial Locations (7)

Florida Eye Clinic, Altamonte Springs

Raj Maturi, Indianapolis

Medical Center Ophthalmology Associates, San Antonio

Valley Retina Institute, McAllen

Derek Kunimoto, Gilbert

Derek Kunimoto, Phoenix

Retina Vitreous Associates Medical Group, Beverly Hills